SCHEMBL11272034

SCHEMBL11272034

O=C1NC(=O)C2(CCCO2)N1

nearest known ligand 0.42

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.34
AKR1B10 O60218 1/20 0.34
MAPT P10636 1/20 0.34
AKR1A1 P14550 1/20 0.34
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12231761 0.71 CRBN (0.36)
SCHEMBL22018249 0.70 MEN1 (0.32) MEN1POLBKMT2A
SCHEMBL12781627 0.67 CRBN (0.36) POLB
SCHEMBL12781625 0.64 PDE7A (0.33) POLB
SCHEMBL11271914 0.64 PDE7A (0.35)
SCHEMBL573862 0.61 CRBN (0.37)
SCHEMBL2706506 0.61 CRBN (0.40)
SCHEMBL542497 0.61 PDE7A (0.47)
SCHEMBL22018246 0.61 LMNA (0.33)
SCHEMBL630549 0.61 CRBN (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4320135-A HORMONE INHIBITORS, ANTIDIABETIC AGENTS, TREATMENT OF MICROANGIOPATHY SANDOZ, INC. (US) 1982-03-16 US claimed